Jump to content
RemedySpot.com

Re: Hello everyone...

Rate this topic


Guest guest

Recommended Posts

congress for fighting both simultaniously and

succesively<br>how u come to know about the ailments u r

suffering<br>also i like to know ur food habits and other daily

routine <br>r u on medicine or on any other alternative

methods<br>and how u have contacted the diseases<br>pl let us

know<br>nARIM

Link to comment
Share on other sites

please find below text note for cihrrosis and

hepatisis C-<br><br><br><br><br><br> CIHRROSIS OF

LIVER<br><br><br> <br><br> <br> Cirrhosis<br> Alternative

names:<br> liver cirrhosis<br> Definition:<br> A chronic

liver disease which causes damage to liver tissue, <br>

scarring of the liver (fibrosis; nodular regeneration),

progressive <br> decrease in liver function, excessive fluid

in the abdomen <br> (ascites), bleeding disorders

(coagulopathy), increased pressure in <br> the blood vessels

(portal hypertension), and brain function <br> disorders

(hepatic encephalopathy).<br> Causes, incidence, and risk

factors:<br> The damaged and scarred liver becomes unable to

adequately remove <br> waste products (toxins) from the

blood, and the formation of scar <br> tissue leads to

increased pressure (portal hypertension) in the <br> veins

between the intestines and spleen to the liver.<br><br>

Excessive alcohol use is the leading cause of cirrhosis

(See <br> Alcoholic liver disease). Other causes

include infections (such as <br> hepatitis), diseases and

defects of the bile drainage system (such <br> as biliary

stenosis or obstruction), cystic fibrosis, and increased

<br> iron and copper absorption.<br><br> The type of

cirrhosis depends on the cause of the disease. <br>

Complications of cirrhosis can be severe. In the U.S. cirrhosis

is <br> the 9th leading cause of death. Neurological

problems (such as <br> hepatic encephalopathy) can

develop. Increased fluid collection in <br> the abdominal

cavity (ascites) is caused by decreased body protein,

<br> increased sodium, and increased pressure within

the liver's blood <br> vessels (portal hypertension).

Portal hypertension can cause <br> increased pressure,

size, and fullness in the blood vessels in the <br>

esophagus (esophageal varices). Problems with bleeding and

clotting <br> can occur. The increased pressures within

the blood vessels and the <br> problems with blood

clotting can increase the possibility of severe <br> and

life-threatening hemorrhage.

Link to comment
Share on other sites

HEPATISIS c<br>ow Hepatitis C Virus Evades The

Immune System<br> <br><br><br> <br><br> How Hepatitis C

Virus Evades The Immune System<br> Scientists from the

National Institutes of Health <br> (NIH) and other

institutions have discovered a <br> clue that begins to

explain why so many patients <br> fail to fully recover

from infection with the <br> hepatitis C virus (HCV).

<br> Their research, reported in the current issue of

<br> Science, points to changes in surface proteins

<br> that enable the virus to evade the immune system.

<br> The study shows that the ultimate outcome of an

<br> HCV infection is determined during the initial,

<br> acute phase of disease. <br> " Hepatitis C is a

devastating disease that exacts <br> a significant toll in

this country and abroad, and <br> whose full clinical

impact has yet to be <br> realized, " states S.

Fauci, M.D., director <br> of the National Institute of

Allergy and <br> Infectious Diseases (NIAID) at the NIH.

" This <br> research helps to explain how the virus

manages to <br> persist in the body and provides

physicians with a <br> potential way to predict the

development of a <br> chronic infection. "

Link to comment
Share on other sites

hepatisis C continues<br>Nearly 4 million

Americans have been infected with <br> the hepatitis C

virus (HCV). Of those who contract <br> hepatitis C, 85

percent remain chronically <br> infected, harboring a

virus that continues to <br> replicate throughout a

person's life. <br> HCV is a major cause of chronic liver

disease and <br> is responsible for a third of all cases

of <br> cirrhosis and liver cancer, half of all

liver <br> transplants, and 8,000 to 10,000 deaths in

this <br> country annually. <br> Patrizia Farci, M.D.,

and Purcell, M.D., of <br> NIAID and Harvey

Alter, M.D., of the NIH Warren <br> Magnuson Clinical

Center, led a team of scientists <br> in a study designed

to see whether the hepatitis C <br> virus changes

during infection. <br> Dr. Alter had been conducting

long-term studies of <br> patients who contracted hepatitis

from blood <br> transfusions. These individuals

subsequently <br> developed different clinical outcomes,

ranging <br> from short-term infections to chronic

disease. <br> Some of these patients have had hepatitis C

for <br> over 20 years.

Link to comment
Share on other sites

hepatisis C continueed 2<br>The research team

examined the virus in each <br> person, looking

specifically for changes in the <br> genes that encode special

proteins coating the <br> viral surface. They also studied

what changes <br> occurred either before or after the

body's immune <br> system responded to HCV infection.

<br> In some patients, the virus remained relatively

<br> unchanged following the initial immune response,

<br> and those people completely eliminated HCV over

<br> several weeks. In most, however, genetic HCV <br>

variants began to appear in response to the early <br>

immune assault. This rapid viral evolution <br>

ultimately resulted in chronic infection. <br> " We know that

the body responds to infection early <br> in the

disease process, but in most patients the <br> virus is

'smarter' than the immune system, " states <br> Dr. Farci.

" In many cases, HCV changes its surface <br> proteins

as soon as the patient's antibodies begin <br> to

attack. In essence, the virus slips into a <br> disguise

and continues on without detection. " <br> Similar

masquerades are used by other viruses, <br> such as HIV and

influenza, but this is the first <br> study to correlate

such behavior with disease <br> progression in

hepatitis C. <br> The researchers also determined a region

on virus <br> surface proteins where most of the

changes occur. <br> Their studies will now focus on the

types of <br> mutations that assist HCV in avoiding the

immune <br> system, and on the types of antibodies

produced <br> during the early response. <br> By

understanding more about this critical <br> checkpoint in HCV

infection, they hope to develop <br> new tools for hepatitis

C treatment and <br> prevention.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...